Quantitative proteomic analysis of the aging brain after intracerebral hemorrhage
脑出血后衰老大脑的定量蛋白质组学分析
基本信息
- 批准号:10433541
- 负责人:
- 金额:$ 7.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-30 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAgeAgingAnimal ModelAnimalsAntibodiesAnticoagulantsBioinformaticsBrainBrain InjuriesCell SeparationCellsCerebral hemisphere hemorrhageChronic PhaseComplexDataDevelopmentDiseaseElderlyFlow CytometryFunctional disorderGeneticGoalsGrantHospitalsHumanIn VitroIncidenceInflammation MediatorsInflammatoryInnate Immune SystemInvestigationIpsilateralKnowledgeLabelLaboratoriesLiquid ChromatographyMass Spectrum AnalysisMediatingMicrogliaMissionMolecularMusNational Institute of Neurological Disorders and StrokeNeurological outcomePathologyPathway interactionsPatient-Focused OutcomesPatientsPhagocytesPhagocytosisPharmacologyPlayPre-Clinical ModelPrevalenceProcessPrognosisProteinsProteomeProteomicsPublic HealthReportingResearchResearch PersonnelRoleStrokeTherapeutic InterventionTimeTranslationsadverse outcomeagedaging brainbasebrain repaircell typeclinically relevantdisabilityeffective therapyexperienceimprovedin vivoinjury and repairmacrophagemolecular targeted therapiesmonocytemortalitynovelnovel therapeutic interventionpatient populationpre-clinicalpreclinical studyresponsetandem mass spectrometrytool
项目摘要
Intracerebral hemorrhage (ICH) is a devastating subtype of stroke with no effective treatment. Lack of
treatment options partly contributes to the poorly defined pathophysiology of ICH. Along these lines, despite
the increasing prevalence of ICH in the elderly, the molecular level changes that occur in the aging brain after
ICH remains largely enigmatic. To address this critical knowledge gap, two specific aims are proposed. Aim 1:
To determine the age-induced changes in the brain proteome after ICH. Aim 2: To determine the age-induced
protein level changes in microglia and brain-infiltrating monocyte-derived macrophages (BMDM) after ICH. The
proposed studies employ a preclinical model of ICH and include unbiased and rigorous proteomics approaches
such as label-free and TMT-labeling Mass spectrometry and bioinformatics approaches. Successful completion
of the project would identify novel molecular regulators to improve the neurological outcomes after ICH in the
elderly. Also, the studies would define, for the first time, the proteomic profile of acutely isolated microglia and
macrophages, the cells that play key roles in brain damage and repair after ICH.
脑出血(ICH)是一种破坏性的中风亚型,没有有效的治疗。缺乏
治疗选择部分导致ICH的病理生理学定义不清。沿着这些路线,尽管
老年人脑出血患病率的增加,
ICH在很大程度上仍然是个谜。为了解决这一关键的知识差距,提出了两个具体目标。目标1:
确定脑出血后脑蛋白质组的年龄诱导变化。目的2:确定年龄诱导的
脑出血后小胶质细胞和脑浸润性单核细胞源性巨噬细胞(BMDM)蛋白水平的变化。的
拟议的研究采用ICH的临床前模型,包括无偏倚和严格的蛋白质组学方法
如无标记和TMT标记质谱法和生物信息学方法。成功完成
该项目将确定新的分子调节剂,以改善脑出血后的神经系统结果,
老人此外,这些研究将首次定义急性分离的小胶质细胞的蛋白质组学特征,
巨噬细胞,在脑出血后的脑损伤和修复中发挥关键作用的细胞。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sangeetha Sukumari-Ramesh其他文献
Sangeetha Sukumari-Ramesh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sangeetha Sukumari-Ramesh', 18)}}的其他基金
HDAC3 as a therapeutic target for intracerebral hemorrhage
HDAC3作为脑出血的治疗靶点
- 批准号:
10701321 - 财政年份:2023
- 资助金额:
$ 7.7万 - 项目类别:
Quantitative proteomic analysis of the aging brain after intracerebral hemorrhage
脑出血后衰老大脑的定量蛋白质组学分析
- 批准号:
10708753 - 财政年份:2022
- 资助金额:
$ 7.7万 - 项目类别:
The Translocator Protein (TSPO) and Intracerebral Hemorrhage
易位蛋白 (TSPO) 和脑出血
- 批准号:
9927694 - 财政年份:2018
- 资助金额:
$ 7.7万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant














{{item.name}}会员




